Advertisement

Topics

NantCell licenses some of GlobeImmune's oncology candidates

15:40 EDT 11 Sep 2017 | Elsevier Business Intelligence

NantCell Inc. licensed exclusive global rights to four of GlobeImmune Inc.’s cancer projects. The deal comes five months af...

Original Article: NantCell licenses some of GlobeImmune's oncology candidates

NEXT ARTICLE

More From BioPortfolio on "NantCell licenses some of GlobeImmune's oncology candidates"

Quick Search
Advertisement
 

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...